Real-World Efficacy Outcomes of FLT3-ITD<sup>mut</sup> Acute Myeloid Leukemia Patients Treated with Midostaurin in Combination with Intensive Induction.

Gueta, Itai; Marcu-Malina, Victoria; Avigdor, Abraham; Shimoni, Avichai; Loebstein, Ronen; Canaani, Jonathan

Real-World Efficacy Outcomes of FLT3-ITD^mut Acute Myeloid Leukemia Patients Treated with Midostaurin in Combination with Intensive Induction.

Gueta, Itai; Marcu-Malina, Victoria; Avigdor, Abraham; Shimoni, Avichai; Loebstein, Ronen; Canaani, Jonathan.

Afiliação

Gueta I; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Marcu-Malina V; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Avigdor A; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Shimoni A; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Loebstein R; Institute of Clinical Pharmacology and Toxicology, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel.
Canaani J; Hematology Division, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Israel. Electronic address: Jonathan.canaani@sheba.health.gov.il.

Clin Lymphoma Myeloma Leuk ; 23(2): 154-157, 2023 02.

Article em En | MEDLINE | ID: mdl-36564312

Assuntos

Leucemia Mieloide Aguda; Humanos; Estaurosporina/farmacologia; Estaurosporina/uso terapêutico; Leucemia Mieloide Aguda/tratamento farmacológico; Tirosina Quinase 3 Semelhante a fms/genética; Mutação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2023 Tipo de documento: Article